{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:27:20Z","timestamp":1782210440768,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12033-024-01240-4","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T02:02:43Z","timestamp":1722477763000},"page":"2598-2606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-1704","authenticated-orcid":false,"given":"Thamby Rajah","family":"Mahendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-8982","authenticated-orcid":false,"given":"Binsin","family":"Cynthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Thevendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-4583","authenticated-orcid":false,"given":"Solayappan","family":"Maheswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.scs.2020.102390","volume":"62","author":"C Sun","year":"2020","unstructured":"Sun, C., & Zhai, Z. (2020). The efficacy of social distance and ventilation effectiveness in preventing COVID-19 transmission. Sustainable Cities and Society, 62, 102390. https:\/\/doi.org\/10.1016\/j.scs.2020.102390","journal-title":"Sustainable Cities and Society"},{"issue":"4","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"102508","DOI":"10.1016\/j.amjoto.2020.102508","volume":"41","author":"C Zhao","year":"2020","unstructured":"Zhao, C., Viana, A., Jr., Wang, Y., Wei, H. Q., Yan, A. H., & Capasso, R. (2020). Otolaryngology during COVID-19: Preventive care and precautionary measures. American Journal of Otolaryngology, 41(4), 102508. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102508","journal-title":"American Journal of Otolaryngology"},{"issue":"3","key":"1240_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s13577-021-00512-4","volume":"34","author":"S Kashte","year":"2021","unstructured":"Kashte, S., Gulbake, A., El-Amin, S. F., III., & Gupta, A. (2021). COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Human Cell, 34(3), 711\u2013733. https:\/\/doi.org\/10.1007\/s13577-021-00512-4","journal-title":"Human Cell"},{"issue":"5","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers, M. M., & Haagmans, B. L. (2022). SARS-CoV-2 pathogenesis. Nature Reviews Microbiology, 20(5), 270\u2013284. https:\/\/doi.org\/10.1038\/s41579-022-00713-0","journal-title":"Nature Reviews Microbiology"},{"issue":"4","key":"1240_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H., & P\u00f6hlmann, S. (2020). A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Molecular Cell, 78(4), 779\u2013784. https:\/\/doi.org\/10.1016\/j.molcel.2020.04.022","journal-title":"Molecular Cell"},{"issue":"4","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K., Wang, Q., Zhou, H., Yan, J., & Qi, J. (2020). Structural and functional basis of SARS-COV-2 entry by using human ACE2. Cell, 181(4), 894-904.e9. https:\/\/doi.org\/10.1016\/j.cell.2020.03.045","journal-title":"Cell"},{"key":"1240_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","author":"X Ou","year":"2020","unstructured":"Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., Xiang, Z., Mu, Z., Chen, X., Chen, J., Hu, K., Jin, Q., Wang, J., & Qian, Z. (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-020-15562-9","journal-title":"Nature Communications"},{"issue":"4","key":"1240_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L., Park, Y. J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., Acton, O. J., Jaconi, S., Guarino, B., Minola, A., Zatta, F., Sprugasci, N., Bassi, J., Peter, A., De Marco, A., & Veesler, D. (2020). Mapping neutralizing and immunodominant sites on the SARS-COV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell, 183(4), 1024-1042.e21. https:\/\/doi.org\/10.1016\/j.cell.2020.09.037","journal-title":"Cell"},{"issue":"1","key":"1240_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H., Dingens, A. S., Nargi, R. S., Sutton, R. E., Suryadevara, N., Rothlauf, P. W., Liu, Z., Whelan, S. P., Carnahan, R. H., Crowe, J. E., & Bloom, J. D. (2021). Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host & Microbe, 29(1), 44-57.e9. https:\/\/doi.org\/10.1016\/j.chom.2020.11.007","journal-title":"Cell Host & Microbe"},{"issue":"6523","key":"1240_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Sch\u00e4fer, A., Nakajima, N., Takahashi, K., Lee, R. E., Mascenik, T. M., Graham, R., Edwards, C. E., Tse, L. V., Okuda, K., Markmann, A. J., Bartelt, L., De Silva, A., \u2026 Baric, R. S. (2020). SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science, 370(6523), 1464\u20131468. https:\/\/doi.org\/10.1126\/science.abe8499","journal-title":"Science"},{"issue":"3","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy, L., Wang, X., Pascal, K. E., Tomkins-Tinch, C., Nyalile, T. P., Wang, Y., Baum, A., Diehl, W. E., Dauphin, A., Carbone, C., Veinotte, K., Egri, S. B., Schaffner, S. F., Lemieux, J. E., Munro, J. B., Rafique, A., Barve, A., Sabeti, P. C., Kyratsous, C. A., \u2026 Luban, J. (2020). Structural and functional analysis of the D614G SARS-COV-2 spike protein variant. Cell, 183(3), 739-751.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.09.032","journal-title":"Cell"},{"issue":"19","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.jmb.2020.07.009","volume":"432","author":"J Chen","year":"2020","unstructured":"Chen, J., Wang, R., Wang, M., & Wei, G. W. (2020). Mutations strengthened SARS-CoV-2 infectivity. Journal of Molecular Biology, 432(19), 5212\u20135226. https:\/\/doi.org\/10.1016\/j.jmb.2020.07.009","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"1240_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama, K., Nainu, F., Frediansyah, A., Yatoo, M. I., Mohapatra, R. K., Chakraborty, S., Zhou, H., Islam, M. R., Mamada, S. S., Kusuma, H. I., Rabaan, A. A., Alhumaid, S., Mutair, A. A., Iqhrammullah, M., Al-Tawfiq, J. A., Mohaini, M. A., Alsalman, A. J., Tuli, H. S., Chakraborty, C., & Harapan, H. (2023). Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. Journal of Infection and Public Health, 16(1), 4\u201314. https:\/\/doi.org\/10.1016\/j.jiph.2022.11.024","journal-title":"Journal of Infection and Public Health"},{"issue":"5","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3201\/eid2705.210191","volume":"27","author":"CKV Nonaka","year":"2021","unstructured":"Nonaka, C. K. V., Franco, M. M., Gr\u00e4f, T., de Lorenzo Barcia, C. A., de \u00c1vila Mendon\u00e7a, R. N., de Sousa, K. A. F., Neiva, L. M. C., Fosenca, V., Mendes, A. V. A., de Aguiar, R. S., Giovanetti, M., & de Freitas Souza, B. S. (2021). Genomic evidence of SARS-COV-2 reinfection involving E484K spike mutation. Brazil. Emerging Infectious Diseases, 27(5), 1522\u20131524. https:\/\/doi.org\/10.3201\/eid2705.210191","journal-title":"Brazil. Emerging Infectious Diseases"},{"issue":"7","key":"1240_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","volume":"29","author":"C Motozono","year":"2021","unstructured":"Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., Yue, Y., Shimizu, R., Ito, J., Torii, S., Yonekawa, A., Shimono, N., Nagasaki, Y., Minami, R., Toya, T., & Sato, K. (2021). SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host & Microbe, 29(7), 1124-1136.e11. https:\/\/doi.org\/10.1016\/j.chom.2021.06.006","journal-title":"Cell Host & Microbe"},{"issue":"2","key":"1240_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jiph.2021.12.014","volume":"15","author":"JA Malik","year":"2022","unstructured":"Malik, J. A., Ahmed, S., Mir, A., Shinde, M., Bender, O., Alshammari, F., Ansari, M., & Anwar, S. (2022). The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. Journal of Infection and Public Health, 15(2), 228\u2013240. https:\/\/doi.org\/10.1016\/j.jiph.2021.12.014","journal-title":"Journal of Infection and Public Health"},{"issue":"4","key":"1240_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","volume":"7","author":"Y Li","year":"2021","unstructured":"Li, Y., Tenchov, R., Smoot, J., Liu, C., Watkins, S., & Zhou, Q. (2021). A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Central Science, 7(4), 512\u2013533. https:\/\/doi.org\/10.1021\/acscentsci.1c00120","journal-title":"ACS Central Science"},{"issue":"10","key":"1240_CR18","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1002\/jmv.27936","volume":"94","author":"K Akash","year":"2022","unstructured":"Akash, K., Sharma, A., Kumar, D., Singh, S. K., Gupta, G., Chellappan, D. K., Dua, K., & Nagraik, R. (2022). Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review. Journal of Medical Virology, 94(10), 4628\u20134643. https:\/\/doi.org\/10.1002\/jmv.27936","journal-title":"Journal of Medical Virology"},{"key":"1240_CR19","doi-asserted-by":"publisher","first-page":"205873842110026","DOI":"10.1177\/205873842110026","volume":"35","author":"S Kausar","year":"2021","unstructured":"Kausar, S., Said Khan, F., Ishaq Mujeeb Ur Rehman, M., Akram, M., Riaz, M., Rasool, G., Hamid Khan, A., Saleem, I., Shamim, S., & Malik, A. (2021). A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology, 35, 20587384211002620. https:\/\/doi.org\/10.1177\/205873842110026","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"1240_CR20","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S315727","author":"MT Mascellino","year":"2021","unstructured":"Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021). Overview of the main anti-SARS-CoV-2 vaccines: Mechanism of action, efficacy and safety. Infection and Drug Resistance. https:\/\/doi.org\/10.2147\/IDR.S315727","journal-title":"Infection and Drug Resistance"},{"issue":"6","key":"1240_CR21","doi-asserted-by":"publisher","first-page":"112621","DOI":"10.1016\/j.celrep.2023.112621","volume":"42","author":"A Addetia","year":"2023","unstructured":"Addetia, A., Park, Y., Starr, T., Greaney, A. J., Sprouse, K. R., Bowen, J. E., Tiles, S. W., Van Voorhis, W. C., Bloom, J. D., Corti, D., Walls, A. C., & Veesler, D. (2023). Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail. Cell Reports, 42(6), 112621. https:\/\/doi.org\/10.1016\/j.celrep.2023.112621","journal-title":"Cell Reports"},{"key":"1240_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32253-9","author":"S Hayek","year":"2022","unstructured":"Hayek, S., Ben-Shlomo, Y., Dagan, N., Reis, B. Y., Barda, N., Kepten, E., Roitman, A., Shapira, S., Yaron, S., Balicer, R. D., Netzer, D., & Peretz, A. (2022). Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-022-32253-9","journal-title":"Nature Communications"},{"key":"1240_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijid.2022.01.067","volume":"117","author":"Y Kakinoki","year":"2022","unstructured":"Kakinoki, Y., Yamada, K., Tanino, Y., Suzuki, K., Ichikawa, T., Suzuki, N., Asari, G., Nakamura, A., Kukita, S., Uehara, A., Saito, S., Kuroda, S., Sakagami, H., Nagashima, Y., Takahashi, K., & Suzuki, S. (2022). Impact of antibody cocktail therapy combined with casirivimab and imdevimab on clinical outcome for patients with COVID-19 in a real-life setting: A single institute analysis. International Journal of Infectious Diseases, 117, 189\u2013194. https:\/\/doi.org\/10.1016\/j.ijid.2022.01.067","journal-title":"International Journal of Infectious Diseases"},{"key":"1240_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37826-w","author":"M Ragonnet-Cronin","year":"2023","unstructured":"Ragonnet-Cronin, M., Nutalai, R., Huo, J., Dijokaite-Guraliuc, A., Das, R., Tuekprakhon, A., Supasa, P., Liu, C., Selvaraj, M., Groves, N., Hartman, H., Ellaby, N., Sutton, J. M., Bahar, M. W., Zhou, D., Fry, E., Ren, J., Brown, C., Klenerman, P., & Rokadiya, S. (2023). Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-023-37826-w","journal-title":"Nature Communications"},{"issue":"3","key":"1240_CR25","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1093\/cid\/ciac625","volume":"76","author":"J Kertes","year":"2022","unstructured":"Kertes, J., David, S. S. B., Engel-Zohar, N., Rosen, K., Hemo, B., Kantor, A., Adler, L., Stein, N. S., Reuveni, M. M., & Shahar, A. (2022). Association between AZD7442 (Tixagevimab-Cilgavimab) administration and Severe Acute respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection, hospitalization, and mortality. Clinical Infectious Diseases\/Clinical Infectious Diseases, 76(3), e126\u2013e132. https:\/\/doi.org\/10.1093\/cid\/ciac625","journal-title":"Clinical Infectious Diseases\/Clinical Infectious Diseases"},{"key":"1240_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00333-23","author":"TL Roe","year":"2023","unstructured":"Roe, T. L., Brady, T., Schuko, N., Nguyen, A., Beloor, J., Guest, J. D., Aksyuk, A. A., Tuffy, K. M., Zhang, T., Streicher, K., Kelly, E. J., & Kijak, G. H. (2023). Molecular characterization of AZD7442 (Tixagevimab-Cilgavimab) neutralization of SARS-COV-2 Omicron subvariants. Microbiology Spectrum. https:\/\/doi.org\/10.1128\/spectrum.00333-23","journal-title":"Microbiology Spectrum"},{"issue":"6","key":"1240_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ccell.2022.05.007","volume":"40","author":"R Stuver","year":"2022","unstructured":"Stuver, R., Shah, G. L., Korde, N. S., Roeker, L. E., Mato, A. R., Batlevi, C. L., Chung, D. J., Doddi, S., Falchi, L., Gyurkocza, B., Hamilton, A., Lin, Y., Jakubowski, A. A., Joffe, E., Landau, H. L., Lin, R. J., Mailankody, S., Palomba, M. L., Park, J. H., & Vardhana, S. A. (2022). Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies. Cancer Cell, 40(6), 590\u2013591. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.007","journal-title":"Cancer Cell"},{"issue":"11","key":"1240_CR28","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/bloodadvances.2022009475","volume":"7","author":"A Chang","year":"2023","unstructured":"Chang, A., Koff, J. L., Lai, L., Orellana-Noia, V. M., Surati, M., Leal, A. M. K., Ellis, M. L., Wali, B., Moreno, A., Linderman, S. L., O\u2019Leary, C. B., Allen, P. B., Churnetski, M. C., Dhodapkar, M. V., Suthar, M. S., Cohen, J. B., & Ahmed, R. (2023). Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies. Blood Advances, 7(11), 2459\u20132462. https:\/\/doi.org\/10.1182\/bloodadvances.2022009475","journal-title":"Blood Advances"},{"key":"1240_CR29","doi-asserted-by":"publisher","first-page":"173496","DOI":"10.1016\/j.ejphar.2020.173496","volume":"885","author":"N Bibi","year":"2020","unstructured":"Bibi, N., Gul, S., Ali, J., & Kamal, M. A. (2020). Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. European Journal of Pharmacology, 885, 173496. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173496","journal-title":"European Journal of Pharmacology"},{"key":"1240_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cegh.2020.07.006","volume":"9","author":"A Frediansyah","year":"2021","unstructured":"Frediansyah, A., Tiwari, R., Sharun, K., Dhama, K., & Harapan, H. (2021). Antivirals for COVID-19: A critical review. Clinical Epidemiology and Global Health, 9, 90\u201398. https:\/\/doi.org\/10.1016\/j.cegh.2020.07.006","journal-title":"Clinical Epidemiology and Global Health"},{"issue":"11","key":"1240_CR31","doi-asserted-by":"publisher","first-page":"e0276751","DOI":"10.1371\/journal.pone.0276751","volume":"17","author":"D De Forni","year":"2022","unstructured":"De Forni, D., Poddesu, B., Cugia, G., Chafouleas, J., Lisziewicz, J., & Lori, F. (2022). Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients. PLoS ONE, 17(11), e0276751. https:\/\/doi.org\/10.1371\/journal.pone.0276751","journal-title":"PLoS ONE"},{"key":"1240_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijid.2023.04.412","volume":"133","author":"D Marangoni","year":"2023","unstructured":"Marangoni, D., Antonello, R. M., Coppi, M., Palazzo, M., Nassi, L., Streva, N., Povolo, L., Malentacchi, F., Zammarchi, L., Rossolini, G. M., Vannucchi, A. M., Bartoloni, A., & Spinicci, M. (2023). Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature. International Journal of Infectious Diseases, 133, 53\u201356. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.412","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"1240_CR33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/hon.3206","volume":"41","author":"Z Pasquini","year":"2023","unstructured":"Pasquini, Z., Toschi, A., Casadei, B., Pellegrini, C., D\u2019Abramo, A., Vita, S., Beccacece, A., Bussini, L., Chionsini, M. C., Dentale, N., Cantiani, A., Lazzarotto, T., Bartoletti, M., Nicastri, E., Zinzani, P., Giannella, M., & Viale, P. (2023). Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection. Hematological Oncology, 41(5), 904\u2013911. https:\/\/doi.org\/10.1002\/hon.3206","journal-title":"Hematological Oncology"},{"key":"1240_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03331-22","author":"J Wagoner","year":"2022","unstructured":"Wagoner, J., Herring, S., Hsiang, T., Ianevski, A., Biering, S. B., Xu, S., Hoffmann, M., P\u00f6hlmann, S., Gale, M., Aittokallio, T., Schiffer, J. T., White, J. M., & Polyak, S. J. (2022). Combinations of host- and virus-targeting antiviral drugs confer synergistic suppression of SARS-COV-2. Microbiology Spectrum. https:\/\/doi.org\/10.1128\/spectrum.03331-22","journal-title":"Microbiology Spectrum"},{"key":"1240_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.omtm.2018.01.010","volume":"8","author":"MC Milone","year":"2018","unstructured":"Milone, M. C., & Bhoj, V. G. (2018). The pharmacology of T cell therapies. Molecular Therapy Methods & Clinical Development, 8, 210\u2013221. https:\/\/doi.org\/10.1016\/j.omtm.2018.01.010","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"11","key":"1240_CR36","doi-asserted-by":"publisher","first-page":"103295","DOI":"10.1016\/j.isci.2021.103295","volume":"24","author":"X Guo","year":"2021","unstructured":"Guo, X., Kazanova, A., Thurmond, S., Saragovi, H. U., & Rudd, C. E. (2021). Effective chimeric antigen receptor T cells against SARS-CoV-2. Iscience, 24(11), 103295. https:\/\/doi.org\/10.1016\/j.isci.2021.103295","journal-title":"Iscience"},{"key":"1240_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01148-0","author":"T Zhu","year":"2021","unstructured":"Zhu, T., Xiao, Y., Meng, X., Tang, L., Li, B., Zhao, Z., Tan, Q., Shan, H., Liu, L., & Huang, X. (2021). Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19. Journal of Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-021-01148-0","journal-title":"Journal of Nanobiotechnology"},{"key":"1240_CR38","doi-asserted-by":"publisher","first-page":"109984","DOI":"10.1016\/j.eurpolymj.2020.109984","volume":"138","author":"J Li","year":"2020","unstructured":"Li, J., & Zhuang, S. (2020). Antibacterial activity of chitosan and its derivatives and their interaction mechanism with bacteria: Current state and perspectives. European Polymer Journal, 138, 109984. https:\/\/doi.org\/10.1016\/j.eurpolymj.2020.109984","journal-title":"European Polymer Journal"},{"issue":"1","key":"1240_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/jam.15202","volume":"132","author":"N Jaber","year":"2022","unstructured":"Jaber, N., Al-Remawi, M., Al-Akayleh, F., Al-Muhtaseb, N., Al-Adham, I. S., & Collier, P. J. (2022). A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19. Journal of Applied Microbiology, 132(1), 41\u201358. https:\/\/doi.org\/10.1111\/jam.15202","journal-title":"Journal of Applied Microbiology"},{"issue":"2","key":"1240_CR40","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jam.15618","volume":"133","author":"D Jang","year":"2022","unstructured":"Jang, D., Lee, D., Shin, Y. C., Lee, J. S., Jung, J., & Ryoo, S. (2022). Low molecular weight chitooligosaccharide inhibits infection of SARS-CoV-2 in vitro. Journal of Applied Microbiology, 133(2), 1089\u20131098. https:\/\/doi.org\/10.1111\/jam.15618","journal-title":"Journal of Applied Microbiology"},{"issue":"1","key":"1240_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40824-023-00351-4","volume":"27","author":"Q Wang","year":"2023","unstructured":"Wang, Q., Song, Y., Kim, M., Hahn, S. K., & Jiang, G. (2023). Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease. Biomaterials Research, 27(1), 13. https:\/\/doi.org\/10.1186\/s40824-023-00351-4","journal-title":"Biomaterials Research"},{"issue":"25","key":"1240_CR42","doi-asserted-by":"publisher","first-page":"15775","DOI":"10.1039\/d2ra00905f","volume":"12","author":"SA Loutfy","year":"2022","unstructured":"Loutfy, S. A., Abdel-Salam, A. I., Moatasim, Y., Gomaa, M. R., Fattah, N. F. A., Emam, M. H., Ali, F., ElShehaby, H. A., Ragab, E. A., El-Din, H. M. A., Mostafa, A., Ali, M. A., & Kasry, A. (2022). Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil\u2013CNPs) against SARS-CoV-2 (in silico and in vitro study). RSC Advances, 12(25), 15775\u201315786. https:\/\/doi.org\/10.1039\/d2ra00905f","journal-title":"RSC Advances"},{"issue":"8","key":"1240_CR43","doi-asserted-by":"publisher","first-page":"e0289139","DOI":"10.1371\/journal.pone.0289139","volume":"18","author":"CM Weiss","year":"2023","unstructured":"Weiss, C. M., Liu, H., Ball, E. E., Hoover, A. R., Wong, T. S., Wong, C. F., Lam, S., Hode, T., Keel, M. K., Levenson, R. M., Chen, W. R., & Coffey, L. L. (2023). N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2. PLoS ONE, 18(8), e0289139. https:\/\/doi.org\/10.1371\/journal.pone.0289139","journal-title":"PLoS ONE"},{"issue":"5","key":"1240_CR44","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jmii.2023.08.001","volume":"56","author":"DS Lin","year":"2023","unstructured":"Lin, D. S., Tzeng, S. C., Cha, T., Hung, C., Lin, W., Yang, C., Lu, H., Chang, J., & Huang, S. (2023). Inhalable chitosan-based hydrogel as a mucosal adjuvant for hydroxychloroquine in the treatment for SARS-CoV-2 infection in a hamster model. Journal of Microbiology, Immunology and Infection, 56(5), 951\u2013960. https:\/\/doi.org\/10.1016\/j.jmii.2023.08.001","journal-title":"Journal of Microbiology, Immunology and Infection"},{"key":"1240_CR45","doi-asserted-by":"publisher","first-page":"105765","DOI":"10.1016\/j.antiviral.2023.105765","volume":"220","author":"S Wang","year":"2023","unstructured":"Wang, S., Cui, H., Zhang, C., Li, W., Wang, W., He, W., Feng, N., Zhao, Y., Wang, T., Tang, X., Yan, F., & Xia, X. (2023). Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters. Antiviral Research, 220, 105765. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105765","journal-title":"Antiviral Research"},{"key":"1240_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.actbio.2023.12.039","volume":"175","author":"AR Hoover","year":"2024","unstructured":"Hoover, A. R., More, S., Liu, K., West, C. L., Valerio, T. I., Furrer, C. L., Adams, J. P., Yu, N., Villalva, C., Kumar, A., Alleruzzo, L., Lam, S. S., Hode, T., Papin, J. F., & Chen, W. R. (2024). N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection. Acta Biomaterialia, 175, 279\u2013292. https:\/\/doi.org\/10.1016\/j.actbio.2023.12.039","journal-title":"Acta Biomaterialia"},{"issue":"8","key":"1240_CR47","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1039\/d1sc04515f","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang, R., Chan, J. F., Wang, S., Li, H., Zhao, J., Ip, T. K., Zuo, Z., Yuen, K., Yuan, S., & Sun, H. (2022). Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy. Chemical Science, 13(8), 2238\u20132248. https:\/\/doi.org\/10.1039\/d1sc04515f","journal-title":"Chemical Science"},{"key":"1240_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.virol.2020.05.002","volume":"547","author":"HA Rothan","year":"2020","unstructured":"Rothan, H. A., Stone, S., Natekar, J., Kumari, P., Arora, K., & Kumar, M. (2020). The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology, 547, 7\u201311. https:\/\/doi.org\/10.1016\/j.virol.2020.05.002","journal-title":"Virology"},{"issue":"66","key":"1240_CR49","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1002\/chem.202004112","volume":"26","author":"M Gil-Moles","year":"2020","unstructured":"Gil-Moles, M., Basu, U., B\u00fcssing, R., Hoffmeister, H., T\u00fcrck, S., Varchmin, A., & Ott, I. (2020). Gold metallodrugs to target coronavirus proteins: inhibitory effects on the spike-ACE2 interaction and on PLpro protease activity by auranofin and gold organometallics. Chemistry\u2014A European Journal, 26(66), 15140\u201315144. https:\/\/doi.org\/10.1002\/chem.202004112","journal-title":"Chemistry\u2014A European Journal"},{"issue":"10","key":"1240_CR50","doi-asserted-by":"publisher","first-page":"105066","DOI":"10.1016\/j.isci.2022.105066","volume":"25","author":"E Laplantine","year":"2022","unstructured":"Laplantine, E., Chable-Bessia, C., Oudin, A., Swain, J., Soria, A., Merida, P., Gourdelier, M., Mestiri, S., Besseghe, I., Bremaud, E., Neyret, A., Lyonnais, S., Favard, C., Benaroch, P., Hubert, M., Schwartz, O., Guerin, M., Danckaert, A., Del Nery, E., \u2026 Weil, R. (2022). The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-\u03baB signaling. iScience, 25(10), 105066. https:\/\/doi.org\/10.1016\/j.isci.2022.105066","journal-title":"iScience"},{"issue":"78","key":"1240_CR51","doi-asserted-by":"publisher","first-page":"10083","DOI":"10.1039\/d1cc03563k","volume":"57","author":"L Panchariya","year":"2021","unstructured":"Panchariya, L., Khan, W. A., Kuila, S., Sonkar, K., Sahoo, S., Ghoshal, A., Kumar, A., Verma, D. K., Hasan, A., Khan, M. A., Jain, N., Mohapatra, A. K., Das, S., Thakur, J. K., Maiti, S., Nanda, R. K., Halder, R., Sunil, S., & Arockiasamy, A. (2021). Zinc2+ion inhibits SARS-CoV-2 main protease and viral replicationin vitro. Chemical Communications, 57(78), 10083\u201310086. https:\/\/doi.org\/10.1039\/d1cc03563k","journal-title":"Chemical Communications"},{"issue":"2","key":"1240_CR52","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/bib\/bbab045","volume":"22","author":"A Rakib","year":"2021","unstructured":"Rakib, A., Nain, Z., Sami, S. A., Mahmud, S., Islam, A., Ahmed, S., Siddiqui, A. B. F., Babu, S. M. O. F., Hossain, P., Shahriar, A., Nainu, F., Emran, T. B., & Simal-Gandara, J. (2021). A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: An in silico investigation. Briefings in Bioinformatics, 22(2), 1476\u20131498. https:\/\/doi.org\/10.1093\/bib\/bbab045","journal-title":"Briefings in Bioinformatics"},{"issue":"8","key":"1240_CR53","doi-asserted-by":"publisher","first-page":"2100028","DOI":"10.1002\/minf.202100028","volume":"40","author":"PA Nogara","year":"2021","unstructured":"Nogara, P. A., Omage, F. B., Bolzan, G. R., Delgado, C. P., Aschner, M., Orian, L., & Teixeira Rocha, J. B. (2021). In silico studies on the interaction between Mpro and PLpro From SARS-CoV-2 and Ebselen, its metabolites and derivatives. Molecular Informatics, 40(8), 2100028. https:\/\/doi.org\/10.1002\/minf.202100028","journal-title":"Molecular Informatics"},{"issue":"3","key":"1240_CR54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1039\/d2sc05473f","volume":"14","author":"J Karges","year":"2023","unstructured":"Karges, J., Giardini, M. A., Blacque, O., Woodworth, B., Siqueira-Neto, J. L., & Cohen, S. M. (2023). Enantioselective inhibition of the SARS-CoV-2 main protease with rhenium (I) picolinic acid complexes. Chemical Science, 14(3), 711\u2013720. https:\/\/doi.org\/10.1039\/d2sc05473f","journal-title":"Chemical Science"},{"issue":"7","key":"1240_CR55","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1039\/d3md00067b","volume":"14","author":"M Gil-Moles","year":"2023","unstructured":"Gil-Moles, M., O\u2019Beirne, C., Esarev, I. V., Lippmann, P., Tacke, M., Cinatl, J., Bojkova, D., & Ott, I. (2023). Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2. RSC Medicinal Chemistry, 14(7), 1260\u20131271. https:\/\/doi.org\/10.1039\/d3md00067b","journal-title":"RSC Medicinal Chemistry"},{"issue":"4","key":"1240_CR56","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., Narayanan, A., Majowicz, S. A., Kwong, E. M., McVicar, R. N., Thacker, B. E., Glass, C. A., Yang, Z., Torres, J. L., Golden, G. J., Bartels, P. L., Porell, R. N., Garretson, A. F., Laubach, L., & Esko, J. D. (2020). SARS-COV-2 infection depends on cellular heparan sulfate and ACE2. Cell, 183(4), 1043-1057.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.09.033","journal-title":"Cell"},{"issue":"6","key":"1240_CR57","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/acscentsci.1c00010","volume":"7","author":"L Liu","year":"2021","unstructured":"Liu, L., Chopra, P., Li, X., Bouwman, K. M., Tompkins, S. M., Wolfert, M. A., De Vries, R. P., & Boons, G. (2021). Heparan sulfate proteoglycans as attachment factor for SARS-COV-2. ACS Central Science, 7(6), 1009\u20131018. https:\/\/doi.org\/10.1021\/acscentsci.1c00010","journal-title":"ACS Central Science"},{"issue":"29","key":"1240_CR58","doi-asserted-by":"publisher","first-page":"15870","DOI":"10.1002\/anie.202102717","volume":"60","author":"C Nie","year":"2021","unstructured":"Nie, C., Pouyan, P., Lauster, D., Trimpert, J., Kerkhoff, Y., Szekeres, G. P., Wallert, M., Block, S., Sahoo, A. K., Dernedde, J., Pagel, K., Kaufer, B. B., Netz, R. R., Ballauff, M., & Haag, R. (2021). Polysulfates block SARS-CoV-2 uptake through electrostatic interactions. Angewandte Chemie, 60(29), 15870\u201315878. https:\/\/doi.org\/10.1002\/anie.202102717","journal-title":"Angewandte Chemie"},{"key":"1240_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10293-x","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Radvak, P., Lee, J., Xu, Y., Cao-Dao, V., Xu, M., Zheng, W., Chen, C. Z., Xie, H., & Ye, Y. (2022). Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-022-10293-x","journal-title":"Scientific Reports"},{"key":"1240_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04789-z","author":"PS Kwon","year":"2023","unstructured":"Kwon, P. S., Xu, S., Oh, H., Kwon, S., Rodrigues, A. L., Feroz, M., Fraser, K., He, P., Zhang, F., Hong, J. J., Linhardt, R. J., & Dordick, J. S. (2023). Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions. Communications Biology. https:\/\/doi.org\/10.1038\/s42003-023-04789-z","journal-title":"Communications Biology"},{"issue":"7909","key":"1240_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","volume":"605","author":"T Shapira","year":"2022","unstructured":"Shapira, T., Monreal, I. A., Dion, S. P., Buchholz, D. W., Imbiakha, B., Olmstead, A. D., Jager, M., D\u00e9silets, A., Gao, G., Martins, M., Vandal, T., Thompson, C. A. H., Chin, A., Rees, W. D., Steiner, T., Nabi, I. R., Marsault, E., Sahler, J., Diel, D. G., & Jean, F. (2022). A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature, 605(7909), 340\u2013348. https:\/\/doi.org\/10.1038\/s41586-022-04661-w","journal-title":"Nature"},{"key":"1240_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00970-21","author":"K Li","year":"2021","unstructured":"Li, K., Meyerholz, D. K., Bartlett, J. A., & McCray, P. B., Jr. (2021). The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19. MBio. https:\/\/doi.org\/10.1128\/mBio.00970-21","journal-title":"MBio"},{"key":"1240_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28124","author":"L Wettstein","year":"2022","unstructured":"Wettstein, L., Immenschuh, P., Weil, T., Conzelmann, C., Almeida-Hern\u00e1ndez, Y., Hoffmann, M., Kempf, A., Nehlmeier, I., Lotke, R., Petersen, M., Stenger, S., Kirchhoff, F., Sauter, D., P\u00f6hlmann, S., Sanchez-Garcia, E., & M\u00fcnch, J. (2022). Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection. Journal of Medical Virology. https:\/\/doi.org\/10.1002\/jmv.28124","journal-title":"Journal of Medical Virology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01240-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:38:27Z","timestamp":1748407107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01240-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01240-4","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}